Discounted Cash Flow
Definitive Healthcare Corp.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2020 | $118.3m | $-51.2m | $19.8m | -43.2% | — |
| 2021 | $166.2m (40.4%) | $-17.7m (65.4%) | $24.6m (23.9%) | -10.6% (75.4%) | — |
| 2022 | $222.7m (34.0%) | $-6.0m (65.8%) | $34.4m (40.1%) | -2.7% (74.5%) | — |
| 2023 | $251.4m (12.9%) | $-202.4m (-3252.5%) | $41.1m (19.6%) | -80.5% (-2868.9%) | — |
| 2024 | $252.2m (0.3%) | $-413.1m (-104.1%) | $51.3m (24.8%) | -163.8% (-103.5%) | — |
| 2025 | $241.5m (-4.2%) | $-138.9m (66.4%) | $49.2m (-4.1%) | -57.5% (64.9%) | — |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.